Description

Contact hours available until 10/31/2020.

Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation.

Nephrology Nursing Journal Editorial Board Statements of Disclosure:
In accordance with ANCC governing rules Nephrology Nursing Journal Editorial Board statements of disclosure are published with each CNE offering. The statements of disclosure for this offering are published below.

Paula Dutka, MSN, RN, CNN, disclosed that she is a coordinator of Clinical Trials for the following sponsors: Amgen, Rockwell Medical, Keryx Biopharmaceuticals, Akebia Therapeutics, and Dynavax Technologies.

Norma J. Gomez, MBA, MSN, CNNe, disclosed that she is a member of the ZS Pharma Advisory Council.

Tamara M. Kear, PhD, RN, CNS, CNN, disclosed that she is a member of the ANNA Board of Directors, serves on the Scientific Advisory Board for Kibow Biotech, Inc., and is employed by Fresenius Kidney Care as an acute hemodialysis RN.

All other members of the Editorial Board had no actual or potential conflict of interest in relation to this continuing nursing education activity.

This article was reviewed and formatted for contact hour credit by Beth Ulrich, EdD, RN, FACHE, FAAN, Nephrology Nursing Journal Editor, and Sally Russell, MN, CMSRN, CPP, ANNA Education Director.

Commercial Support and Sponsorship:
No commercial support or sponsorship declared.

Accreditation Statement:
American Nephrology Nurses Association – Provider is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

ANNA is a provider approved by the California Board of Registered Nursing, provider number CEP 00910.

This CNE article meets the Nephrology Nursing Certification Commission’s (NNCC’s) continuing nursing education requirements for certification and recertification.

Learning Outcome:
After completing this learning activity, the learner will be able to discuss the impact of ultrasound-guided cannulation, patient diabetes status and age, fistula age, and years of cannulator experience on the number of missed cannulations within the study’s focused patient population.

Learning Engagement Activity:
For more information on cannulation techniques in specific populations, view the following article: Stolic, R.V., Trajkovic, G.Z., Kostic, M.M., Lazic, B.D., Odalovic, B., Smilic, T.N., & Mitic, J.S. (2017). Cannulation technique and arteriovenous fistula survival in elderly patients on hemodialysis. Nephrology Nursing Journal, 44(5), 441-446: Click Here! (Additional costs may be associated)

Author(s)

• Alice Luehr, DNP, RN, CNN , Director of Dialysis, St. Peter's Health